New research reveals that patients who come off blockbuster weight-loss injections like semaglutide or tirzepatide may regain reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise regimens.
Published data in a prominent health publication points out that while obese individuals frequently drop a large proportion of their body weight while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month once they quit.
"Individuals buying these medications should be cognizant of the risk of fast rebound weight gain when the therapy is stopped," stated expert Dr. Susan Jebb.
That rate of recovery implies a return to original weight in about 18 months.
Analyzing Treatments
The research, which looked at 37 of trials involving over 9,000 of participants, contrasted the results of GLP-1 agonists with other pills.
Scientists emphasize that people who lose weight through lifestyle changes alone usually experience a slower creep back—approximately 0.1 kg a month—after stopping.
Explaining the Fast Regain
Doctors believe the mechanism of the injections accounts for the amplified rebound.
The injections copy a body's own chemical called GLP-1, which helps regulate appetite.
"Long-term administration of GLP-1 concentrations several times higher than normal might result in the system to generate a reduced amount of its endogenous GLP-1, and could reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement means appetite is uncontrolled, making overeating a significant risk."
A Chronic Disease?
The NHS suggest the injections for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
Many experts say that, due to the likelihood of relapse, the therapy might need to be life-long.
This opinion is supported by pharmaceutical companies, who note that the results "underscore the persistent nature of obesity," comparing it to managing diseases like hypertension.
User Testimonies
People who have come off the medication report a sudden resurgence of hunger.
"It was like a trigger flipping and you're instantly extremely hungry," said an individual.
The struggle is compounded if patients have not developed lasting dietary or behavioural modifications during treatment.
Growing Interest
Survey data show that millions of people in the UK have tried weight-loss jabs in the past year, with interest being substantial.
- Use is higher among females than males.
- The middle-aged demographic shows the highest usage rates.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, experts emphasize that while these medications are effective tools for weight loss, they are not a magic solution and lasting health benefits likely depends on ongoing lifestyle support.
